These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 22924504)
21. Back to the future: the 'old-fashioned' way to new medications for neurodegeneration. Lansbury PT Nat Med; 2004 Jul; 10 Suppl():S51-7. PubMed ID: 15298008 [TBL] [Abstract][Full Text] [Related]
22. [Cellular therapy in neurodegenerative diseases: perspective from the experimental model of Parkinson's disease]. Sánchez Pernaute R Neurologia; 2003 Sep; 18(7):355-6. PubMed ID: 14505242 [No Abstract] [Full Text] [Related]
24. Neural transplantation therapy: trying the tougher experiment. Figlewicz DA Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Dec; 2(4):173-4. PubMed ID: 11958727 [No Abstract] [Full Text] [Related]
25. [Gene and gene cellular therapy and neurodegenerative diseases]. Ugriumov MV; Ermakov AS; Popov AP; Zhdanov RI Vopr Med Khim; 2000; 46(3):311-23. PubMed ID: 11033889 [TBL] [Abstract][Full Text] [Related]
26. Stem cell therapy for human neurodegenerative disorders-how to make it work. Lindvall O; Kokaia Z; Martinez-Serrano A Nat Med; 2004 Jul; 10 Suppl():S42-50. PubMed ID: 15272269 [TBL] [Abstract][Full Text] [Related]
27. Promising Targets for the Treatment of Neurodegenerative Diseases. Budd Haeberlein SL; Harris TJ Clin Pharmacol Ther; 2015 Nov; 98(5):492-501. PubMed ID: 26250447 [TBL] [Abstract][Full Text] [Related]
28. Adult neurogenesis as a potential therapy for neurodegenerative diseases. Jordan JD; Ming GL; Song H Discov Med; 2006 Aug; 6(34):144-7. PubMed ID: 17234134 [TBL] [Abstract][Full Text] [Related]
29. Pharmacological intervention of early neuropathy in neurodegenerative diseases. Kwon MJ; Kim JH; Kim T; Lee SB Pharmacol Res; 2017 May; 119():169-177. PubMed ID: 28167240 [TBL] [Abstract][Full Text] [Related]
30. Can endogenous stem cells be stimulated to repair the degenerating brain? Michell AW; Phillips W; Barker RA J Pharm Pharmacol; 2004 Oct; 56(10):1201-10. PubMed ID: 15482633 [No Abstract] [Full Text] [Related]
31. Perspective on the pipeline of drugs being developed with modulation of DNA damage as a target. Plummer R Clin Cancer Res; 2010 Sep; 16(18):4527-31. PubMed ID: 20823148 [TBL] [Abstract][Full Text] [Related]
33. Therapeutic applications of iminosugars: current perspectives and future opportunities. Horne G; Wilson FX Prog Med Chem; 2011; 50():135-76. PubMed ID: 21315930 [No Abstract] [Full Text] [Related]
34. Stem cells as a resource for regenerative neurology. Connick P; Patani R; Chandran S Pract Neurol; 2011 Feb; 11(1):29-36. PubMed ID: 21239652 [TBL] [Abstract][Full Text] [Related]
35. Neurosurgery for the 21st century. What does neurobiology justify for repairing neurodegenerative disorders? Sanberg PR; Willing AE; Cahill DW Clin Neurosurg; 2001; 48():113-26. PubMed ID: 11692635 [No Abstract] [Full Text] [Related]
36. Accelerating the discovery of new drug targets with chemical proteomics. Cheung AK; Jain RK IDrugs; 2010 Dec; 13(12):862-8. PubMed ID: 21154144 [TBL] [Abstract][Full Text] [Related]
37. Multi-targeted hybrids based on HDAC inhibitors for anti-cancer drug discovery. Seo SY Arch Pharm Res; 2012 Feb; 35(2):197-200. PubMed ID: 22370774 [TBL] [Abstract][Full Text] [Related]
38. Adult stem cells for neuronal repair. Barzilay R; Levy YS; Melamed E; Offen D Isr Med Assoc J; 2006 Jan; 8(1):61-6. PubMed ID: 16450758 [No Abstract] [Full Text] [Related]
39. Stem cell therapy: opportunities and challenges. England S Curr Opin Investig Drugs; 2004 Jul; 5(7):704-5. PubMed ID: 15298064 [No Abstract] [Full Text] [Related]
40. Autotransplantation of bone marrow-derived stem cells as a therapy for neurodegenerative diseases. Kan I; Melamed E; Offen D Handb Exp Pharmacol; 2007; (180):219-42. PubMed ID: 17554511 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]